Gene delivery strategies targeting stable atheromatous plaque.
Conventional therapeutic options to treat chronic angina pectoris are pharmacological interventions, coronary bypass surgery (CABG) and percutaneous coronary intervention (PCI). In animal models, it was shown that gene delivery strategies harbour an exciting potential to support and maybe even repla...
Autors principals: | Van-Assche, T, Huygelen, V, Crabtree, M, Antoniades, C |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2013
|
Ítems similars
-
Gene therapy targeting inflammation in atherosclerosis.
per: Van-Assche, T, et al.
Publicat: (2011) -
Targeting vascular redox biology through antioxidant gene delivery: a historical view and current perspectives.
per: Van Assche, T, et al.
Publicat: (2011) -
Periodontal pathogens in atheromatous plaque
per: Saroj K. Rath, et al.
Publicat: (2014-01-01) -
Macrophages in Atheromatous Plaque Developmental Stages
per: Alexander von Ehr, et al.
Publicat: (2022-04-01) -
Letter to the Editor. Atheromatous Plaque Vulnerability — the Neglected Vulnerable Carotid Plaques
per: Péter Levente
Publicat: (2017-09-01)